Pharma Struggles To Escape FCPA Net
The U.S. government's Foreign Corrupt Practices Act investigation of the pharmaceutical industry exposes major drugmakers to untold risks and gives executives the Herculean task of controlling the way business is conducted...To view the full article, register now.
Already a subscriber? Click here to view full article